NCT02482454

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

• Status: Active Not Recruiting
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: The First People's Hospital of Changzhou · Academic / Other
• Sex: All
• Age: 30 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with cholangiocarcinoma.

Detailed description

The primary objective is to evaluate whether RFA followed by CIK transfusion can prolong survival of patients with cholangiocarcinoma.

Conditions

• Cholangiocarcinoma

Interventions

Type	Name	Description
PROCEDURE	Radiofrequency ablation	Radiofrequency ablation is performed percutaneously under CT/US guidance
BIOLOGICAL	Cytokine-induced killer cells	The patients received autologous cytokine-induced killer cells transfusion one week after RFA treatment.

Timeline

• Start date: 2012-07-01
• Primary completion: 2030-07-01
• Completion: 2033-07-01
• First posted: 2015-06-26
• Last updated: 2017-08-01

Locations

1 site across 1 country: China